DrugPatentWatch Database Preview

Hope Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for HOPE PHARMS, and what generic alternatives to HOPE PHARMS drugs are available?

HOPE PHARMS has three approved drugs.

There are four US patents protecting HOPE PHARMS drugs.

There are twenty-one patent family members on HOPE PHARMS drugs in eight countries and thirty-one supplementary protection certificates in seven countries.

Summary for Hope Pharms

International Patents:	21
US Patents:	4
Tradenames:	3
Ingredients:	3
NDAs:	3

Drugs and US Patents for Hope Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hope Pharms	NITHIODOTE	sodium nitrite; sodium thiosulfate	SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS	201444-001	Jan 14, 2011		RX	Yes	Yes	8,568,793		Y	Y
Hope Pharms	SODIUM THIOSULFATE	sodium thiosulfate	SOLUTION;INTRAVENOUS	203923-001	Feb 14, 2012		RX	Yes	Yes	9,345,724		Y	Y
Hope Pharms	SODIUM NITRITE	sodium nitrite	SOLUTION;INTRAVENOUS	203922-001	Feb 14, 2012		RX	Yes	Yes
Hope Pharms	NITHIODOTE	sodium nitrite; sodium thiosulfate	SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS	201444-001	Jan 14, 2011		RX	Yes	Yes	9,345,724		Y	Y

Non-Orange Book US Patents for Hope Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
9,597,354	Sodium nitrite-containing pharmaceutical compositions
9,579,345	Sodium thiosulfate-containing pharmaceutical compositions
8,715,746	Sodium thiosulfate-containing pharmaceutical compositions
9,504,709	Sodium nitrite-containing pharmaceutical compositions

International Patents for Hope Pharms Drugs

Country	Document Number	Estimated Expiration
Japan	2015199764
Japan	5789519
Denmark	2451435
European Patent Office	2395834

Supplementary Protection Certificates for Hope Pharms Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0041	France		PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418
595	Luxembourg		PRODUCT NAME: SIMEPREVIR, OU L UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, INCLUANT SIMEPREVIR SODIUM. FIRST REGISTRATION: 20140516
15/009	Ireland		PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REGISTRATION NO/DATE: EU/1/14/983 20150115
C0052	France		PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Hope Pharms